Ligand Activation of ERRα by Cholesterol Mediates Statin and Bisphosphonate Effects

Andersson, 2002, Desmosterolosis presenting with multiple congenital anomalies and profound developmental delay, Am. J. Med. Genet., 113, 315, 10.1002/ajmg.b.10873 Ascenzi, 2006, Structure-function relationship of estrogen receptor alpha and beta: impact on human health, Mol. Aspects Med., 27, 299, 10.1016/j.mam.2006.07.001 Ayers, 2007, Continuous nucleocytoplasmic shuttling underlies transcriptional activation of PPARgamma by FABP4, Biochemistry, 46, 6744, 10.1021/bi700047a Bookout, 2006, Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network, Cell, 126, 789, 10.1016/j.cell.2006.06.049 Brown, 1997, The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor, Cell, 89, 331, 10.1016/S0092-8674(00)80213-5 Chakravarthy, 2009, Identification of a physiologically relevant endogenous ligand for PPARalpha in liver, Cell, 138, 476, 10.1016/j.cell.2009.05.036 Cuzick, 2011, Preventive therapy for breast cancer: a consensus statement, Lancet Oncol., 12, 496, 10.1016/S1470-2045(11)70030-4 Duellman, 2010, A novel steroidal inhibitor of estrogen-related receptor alpha (ERR alpha), Biochem. Pharmacol., 80, 819, 10.1016/j.bcp.2010.05.024 Echaniz-Laguna, 2010, Neuromuscular symptoms and elevated creatine kinase after statin withdrawal, N. Engl. J. Med., 362, 564, 10.1056/NEJMc0908215 Eskiocak, 2014, The estrogen-related receptor α inverse agonist XCT 790 is a nanomolar mitochondrial uncoupler, Biochemistry, 53, 4839, 10.1021/bi500737n FitzPatrick, 1998, Clinical phenotype of desmosterolosis, Am. J. Med. Genet., 75, 145, 10.1002/(SICI)1096-8628(19980113)75:2<145::AID-AJMG5>3.0.CO;2-S Flück, 2004, Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome, Nat. Genet., 36, 228, 10.1038/ng1300 Gallet, 2010, ERR receptors as potential targets in osteoporosis, Trends Endocrinol. Metab., 21, 637, 10.1016/j.tem.2010.06.008 Giguère, 2002, To ERR in the estrogen pathway, Trends Endocrinol. Metab., 13, 220, 10.1016/S1043-2760(02)00592-1 Giguère, 2008, Transcriptional control of energy homeostasis by the estrogen-related receptors, Endocr. Rev., 29, 677, 10.1210/er.2008-0017 Giguère, 1988, Identification of a new class of steroid hormone receptors, Nature, 331, 91, 10.1038/331091a0 Greschik, 2008, Communication between the ERRalpha homodimer interface and the PGC-1alpha binding surface via the helix 8-9 loop, J. Biol. Chem., 283, 20220, 10.1074/jbc.M801920200 Hanai, 2007, The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity, J. Clin. Invest., 117, 3940 Horard, 2003, Estrogen receptor-related receptors: orphan receptors desperately seeking a ligand, J. Mol. Endocrinol., 31, 349, 10.1677/jme.0.0310349 Huss, 2004, Estrogen-related receptor alpha directs peroxisome proliferator-activated receptor alpha signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle, Mol. Cell. Biol., 24, 9079, 10.1128/MCB.24.20.9079-9091.2004 Johnston, 2003, Aromatase inhibitors for breast cancer: lessons from the laboratory, Nat. Rev. Cancer, 3, 821, 10.1038/nrc1211 Kallen, 2004, Evidence for ligand-independent transcriptional activation of the human estrogen-related receptor alpha (ERRalpha): crystal structure of ERRalpha ligand binding domain in complex with peroxisome proliferator-activated receptor coactivator-1alpha, J. Biol. Chem., 279, 49330, 10.1074/jbc.M407999200 Kim, 2011, A metabolomics strategy for detecting protein-metabolite interactions to identify natural nuclear receptor ligands, Mol. Biosyst., 7, 1046, 10.1039/c0mb00324g Kong, 1999, OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis, Nature, 397, 315, 10.1038/16852 Kumar, 2008, Estrogen receptor-negative breast cancer is less likely to arise among lipophilic statin users, Cancer Epidemiol. Biomarkers Prev., 17, 1028, 10.1158/1055-9965.EPI-07-0726 Luo, 2003, Reduced fat mass in mice lacking orphan nuclear receptor estrogen-related receptor alpha, Mol. Cell. Biol., 23, 7947, 10.1128/MCB.23.22.7947-7956.2003 McDonald, 2007, Extraction and analysis of sterols in biological matrices by high performance liquid chromatography electrospray ionization mass spectrometry, Methods Enzymol., 432, 145, 10.1016/S0076-6879(07)32006-5 Novack, 2008, The osteoclast: friend or foe?, Annu. Rev. Pathol., 3, 457, 10.1146/annurev.pathmechdis.3.121806.151431 Orozco, 2004, Atherogenic lipid profile and elevated lipoprotein (a) are associated with lower bone mineral density in early postmenopausal overweight women, Eur. J. Epidemiol., 19, 1105, 10.1007/s10654-004-1706-8 Patch, 2011, Identification of diaryl ether-based ligands for estrogen-related receptor α as potential antidiabetic agents, J. Med. Chem., 54, 788, 10.1021/jm101063h Russell, 2011, Bisphosphonates: the first 40 years, Bone, 49, 2, 10.1016/j.bone.2011.04.022 Sathasivam, 2012, Statin induced myotoxicity, Eur. J. Intern. Med., 23, 317, 10.1016/j.ejim.2012.01.004 Schaaf, 2011, Desmosterolosis-phenotypic and molecular characterization of a third case and review of the literature, Am. J. Med. Genet. A., 155A, 1597, 10.1002/ajmg.a.34040 Sladek, 1997, The orphan nuclear receptor estrogen-related receptor alpha is a transcriptional regulator of the human medium-chain acyl coenzyme A dehydrogenase gene, Mol. Cell. Biol., 17, 5400, 10.1128/MCB.17.9.5400 Smith, 2006, XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification, Anal. Chem., 78, 779, 10.1021/ac051437y Spann, 2012, Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses, Cell, 151, 138, 10.1016/j.cell.2012.06.054 Stein, 2006, Estrogen-related receptor alpha as a therapeutic target in cancer, Endocr. Relat. Cancer, 13, S25, 10.1677/erc.1.01292 Suzuki, 2004, Estrogen-related receptor alpha in human breast carcinoma as a potent prognostic factor, Cancer Res., 64, 4670, 10.1158/0008-5472.CAN-04-0250 Tagore, 2008, A global metabolite profiling approach to identify protein-metabolite interactions, J. Am. Chem. Soc., 130, 14111, 10.1021/ja806463c Tarakida, 2011, Hypercholesterolemia accelerates bone loss in postmenopausal women, Climacteric, 14, 105, 10.3109/13697137.2010.507888 Toledano, 2000, Statins: not just for cholesterol?, Trends Endocrinol. Metab., 11, 255, 10.1016/S1043-2760(00)00295-2 Tomaszewski, 2011, Statin-induced myopathies, Pharmacological Rep., 63, 859, 10.1016/S1734-1140(11)70601-6 Tremblay, 2001, Diethylstilbestrol regulates trophoblast stem cell differentiation as a ligand of orphan nuclear receptor ERR beta, Genes Dev., 15, 833, 10.1101/gad.873401 Trott, 2010, AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading, J. Comput. Chem., 31, 455 Vinayavekhin, 2011, Discovery of a protein-metabolite interaction between unsaturated fatty acids and the nuclear receptor Nur77 using a metabolomics approach, J. Am. Chem. Soc., 133, 17168, 10.1021/ja208199h Walsh, 2012, Heart drugs that affect bone, Trends Endocrinol. Metab., 23, 163, 10.1016/j.tem.2011.10.002 Wan, 2010, PPARgamma in bone homeostasis. Trends in endocrinology and metabolism, Trends Endocrinol. Metab., 21, 722, 10.1016/j.tem.2010.08.006 Wei, 2010, PGC1beta mediates PPARgamma activation of osteoclastogenesis and rosiglitazone-induced bone loss, Cell Metab., 11, 503, 10.1016/j.cmet.2010.04.015 Wei, 2011, Biphasic and dosage-dependent regulation of osteoclastogenesis by β-catenin, Mol. Cell. Biol., 31, 4706, 10.1128/MCB.05980-11 Wu, 2009, Estrogen-related receptor alpha (ERRalpha) inverse agonist XCT-790 induces cell death in chemotherapeutic resistant cancer cells, Chem. Biol. Interact., 181, 236, 10.1016/j.cbi.2009.05.008 Xing, 2013, Targeted disruption of leucine-rich repeat kinase 1 but not leucine-rich repeat kinase 2 in mice causes severe osteopetrosis, J. Bone Miner. Res., 28, 1962, 10.1002/jbmr.1935